News
09-25-2008, 10:00 AM
While raloxifene and tamoxifen are similarly effective in reducingbreast cancer risk, raloxifene also appears to lower the risk ofdeveloping endometrial cancer, researchers report in the September1st issue of the Journal of Clinical Oncology.
More... (http://www.healthcentral.com/breast-cancer/news-264389-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-264389-66.html)